Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

218
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
218
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

35
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
35
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.0K
Clinical Trials01:16

Clinical Trials

9.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.9K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

375
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
375
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

571
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
571

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular Disease Risk Prediction in Patients With Metabolic Dysfunction-Associated Steatohepatitis.

Diabetes, obesity & metabolism·2026
Same author

Response to Comment on Rossing et al. Nuances in Interpretation: Assessing the Interaction Between Semaglutide and MRAs in the FLOW Trial.

Diabetes care·2026
Same author

Semaglutide, weight loss, and cardiovascular outcomes in the SELECT trial - Authors' reply.

Lancet (London, England)·2026
Same author

Validation and Reliability of the Spanish Internet Addiction Test-7 (IAT-7) for Adolescents.

European journal of investigation in health, psychology and education·2026
Same author

Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical Trial.

JAMA internal medicine·2026
Same author

Smartphone and Social Network Addiction, Physical Activity, and Self-Esteem Among Spanish Adolescents: A Cross-Sectional Study of Associations and Gender Differences.

Psychological reports·2026
Same journal

Automated lung cancer classification using intensity-driven RoI selection and transfer learning.

BMC medical informatics and decision making·2026
Same journal

Generating Alzheimer's narratives using large language models.

BMC medical informatics and decision making·2026
Same journal

Leveraging human-centered AI for clinical decision-making: a transparent, accurate rule extractor using non-dominated sorting genetic algorithm.

BMC medical informatics and decision making·2026
Same journal

Augmenting medical data interpretation with Large Language Models (LLMs): a comparative analysis of patient empowerment, information processing, and technology acceptance.

BMC medical informatics and decision making·2026
Same journal

A multicenter machine learning model for predicting ICU mortality in mechanically ventilated patients: development and external validation.

BMC medical informatics and decision making·2026
Same journal

An explainable machine learning model for predicting high phosphorus risk in patients on maintenance hemodialysis: a multicenter retrospective study.

BMC medical informatics and decision making·2026
See all related articles

Related Experiment Video

Updated: Nov 5, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.8K

Surrogate endpoint evaluation using data from one large global randomized controlled trial.

Milan Geybels1, Benjamin Ole Wolthers1, Frederik Flindt Kreiner2

  • 1Novo Nordisk A/S, Vandtårnsvej 110-114, 2860, Søborg, Denmark.

BMC Medical Informatics and Decision Making
|May 21, 2021
PubMed
Summary
This summary is machine-generated.

This study shows that a modified meta-analysis approach can validate surrogate endpoints using data from a single large trial. This method accelerates drug development by using major adverse cardiovascular events (MACE) to predict cardiovascular death.

Keywords:
Cardiovascular outcomesDrug developmentSurrogate endpoint evaluationSurrogate endpointsSurvival

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.5K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.9K

Related Experiment Videos

Last Updated: Nov 5, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.8K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.5K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.9K

Area of Science:

  • Pharmacology
  • Clinical Trials
  • Biostatistics

Background:

  • Robust identification of surrogate endpoints can accelerate pharmacotherapy development.
  • The Surrogate Endpoint Evaluation (SEE) meta-analysis integrates data from multiple trials.
  • This study tested SEE applicability using a single large trial (LEADER).

Purpose of the Study:

  • To evaluate the Surrogate Endpoint Evaluation (SEE) method using data from a single, large clinical trial.
  • To determine if grouping trial data by country facilitates meta-analysis for surrogate endpoint validation.
  • To assess the surrogacy of major adverse cardiovascular events (MACE) for cardiovascular death.

Main Methods:

  • The LEADER trial data (liraglutide for diabetes) was grouped by country.
  • A two-step SEE was performed: group-specific Cox models followed by trial-level regression.
  • Hazard ratios for true endpoints (CV death, all-cause death) were regressed on the HR for MACE.

Main Results:

  • Major adverse cardiovascular events (MACE) adequately surrogated cardiovascular death (R²=0.85).
  • MACE did not adequately surrogate all-cause death (R²=0.23).
  • Sensitivity analyses confirmed the robustness of the grouping approach and conclusions.

Conclusions:

  • A specific data-grouping approach enables successful application of SEE on single-trial data.
  • This method allows robust identification and validation of surrogate endpoints from large outcome trials.
  • This approach is particularly relevant for drug development in areas like diabetes.